Trial Profile
A Randomized, Open-Label, 5-Period Crossover Study to Evaluate the Effect of Meal Type and Timing on the Pharmacokinetics of Migalastat Hydrochloride in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Dec 2013
Price :
$35
*
At a glance
- Drugs Migalastat (Primary)
- Indications Fabry's disease
- Focus Pharmacokinetics
- Sponsors Amicus Therapeutics
- 21 Dec 2013 New trial record